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Edited by Irmgard SinningAbstract The oligomerization state of the ADP/ATP carrier is
an important issue in understanding the mechanism underlying
nucleotide exchange across the inner mitochondrial membrane.
The ﬁrst high resolution structure obtained in the presence of
carboxyatractyloside revealed a large cavity formed within a
monomer in which the inhibitor is strongly bound. Whereas the
protein–protein interactions implicated in the ﬁrst crystal form
are not biologically relevant, the new crystal form described
herein, highlights favorable protein–protein interactions. The
interactions are mediated by endogenous cardiolipins, which
are tightly bound to the protein, two cardiolipins being sand-
wiched between the monomers on the matrix side. The putative
dimerization interface evidenced here is consistent with other
structural, biochemical or functional data published so far.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The transport of small molecules over the mitochondrial
membranes needed in major metabolic pathways occurring
within mitochondria is essential in eukaryotic metabolism.
Integral membrane proteins from the mitochondrial carrier
family (MCF) transport various metabolites over the inner
mitochondrial membrane [1,2]. MCF genes probably result
from two sequential duplications of a common ancestral gene
and therefore encode proteins containing three repeats of
about a hundred amino acids each. Generally, each repeat
exhibits the characteristic sequence, PXD/EXXK/R. Hydro-
phobic pattern analyses highlight six putative transmembrane
helices within the whole sequence. The ADP/ATP carrier
(AAC) was the ﬁrst to be characterized among the members
of the MCF family [3]. It is related to the oxidative phosphor-
ylation pathway as it imports ADP to the mitochondrial ma-
trix while it exports ATP toward the cytosol after synthesis.
AAC is the most abundant among MCF carriers (up to 10%*Corresponding author. Fax: +33 0 4 38 78 94 84.
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to shuttle large quantities of nucleotides in order to fulﬁll ener-
getic cellular requests. Because of its natural abundance, AAC
can be extracted and puriﬁed from mitochondria and was
therefore extensively studied and characterized [4,5]. Two nat-
ural inhibitors, carboxyatractyloside (CATR) and bongkrekic
acid (BA), interact with two diﬀerent conformations, which
may represent the extreme conformations adopted by the car-
rier during the transport process. In the last two decades, sev-
eral experimental data indicated that the functional unit of
AAC is an oligomer, and possibly a dimer [5]. Two models
were proposed in which either the 12 helices of two monomers
form a single pathway allowing both ADP and ATP to cross
over the membrane, or the six helices of each monomer form
one pathway. In the latter hypothesis, a cross-talk between
the two monomers has to occur in order to explain the simul-
taneous import of ADP and export of ATP. The ﬁrst structural
results coming from 2D projection maps obtained by electron
microscopy showed an assembly of proteins in which a possi-
ble dimer was postulated [6]. The recent structure of the bovine
heart AAC solved to 2.2 A˚ resolution [7] showed that the
monomer complexed to CATR is composed of six transmem-
brane helices that form a bundle. The tilts of transmembrane
helices with respect to the membrane and the kinks of three
of them, create a cavity widely open toward the intermem-
brane space and entering deeply (up to 30 A˚) into the protein.
The cavity is tightly closed toward the matrix. The structure
clearly ruled out the model in which 12 helices form a single
nucleotide pathway. However, no evidence for a dimeric struc-
ture could be detected from the crystal packing. Further inter-
pretations of the transport mechanism involving possible
cross-talks between monomers could therefore not be ascer-
tained. This limitation raises several questions (1) is the func-
tional unit in vivo a dimer? and/or (2) if yes, does the
nucleotide transport in reconstituted systems in liposomes
have to be a dimer or can monomers and dimers be both func-
tional?, or (3) is the monomeric state observed in the crystal
simply an artefact due to the crystallization process where high
detergent concentrations are present?
In order to address these questions, another crystal form of
the bovine ADP/ATP carrier also obtained in the presence of
CATR was analyzed. We detail herein the diﬀerent protein–
protein interactions observed in the crystal. One of the possi-
bilities, also mediated by cardiolipins, implicates a largerblished by Elsevier B.V. All rights reserved.
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with other experimental data published so far.2. Material and methods
2.1. Protein puriﬁcation
The protein was extracted from bovine heart muscle mitochondria
that were incubated with carboxyactractyloside, in the presence of
2% (w/v) 3-laurylamido-N,N 0-dimethylpropylaminoxyde (LAPAO).
The CATR-carrier complex was puriﬁed by hydroxylapatite (HTP)
chromatography and gel ﬁltration according to a previous protocol
[8] with a gel ﬁltration buﬀer containing 0 or 5 mM NaCl. The deter-
gent-to-protein ratio was reduced by incubating the protein solution in
the presence of Bio-Beads [8]. Finally, the protein was concentrated on
an Amicon Ultra device (Millipore) to about 5 mg/mL.
2.2. Crystallization
Crystallization was performed by vapor-diﬀusion using hanging-
drops composed of 1 lL of the protein solution and 1 lL of the reser-
voir solution. The reservoir contained 28–32% of Jeﬀamine M600
(Hampton Research) as a precipitant, 10–20 mM NiSO4 (or 5 mM
Na citrate and 50 mM Na arseniate) and 100 mM HEPES, pH 7.0
(or 100 mM Tris, pH 8.5). Plate-shaped crystals with typical sizes of
100 · 20 · 5 lm3 grew within days at 20 C.
2.3. Data collection, structure determination and reﬁnement
Crystals ﬁshed from the mother liquor were ﬂash-frozen in liquid
nitrogen. Diﬀraction data were collected at 100 K under nitrogen
stream on beamline BM30A at the European Synchrotron Radiation
Facility (ESRF, Grenoble). The data were processed using DENZO,
SCALEPACK [9] and programs from the CCP4 suite [10]. Data collec-
tion statistics are listed in Table 1. Crystals obtained from low salt buf-
fers during puriﬁcation have C2221 space groups with typical unit cell
parameters of a = 80 A˚, b = 109 A˚, c = 89 A˚ or a = 76 A˚, b = 111 A˚,
c = 90 A˚. The smaller unit cell was systematically obtained from pro-
teins puriﬁed in the absence of NaCl (data set 2 in Table 1). Proteins
puriﬁed with 5 mM NaCl led to the larger unit cell except for one crys-
tal (data set 1 in Table 1). The initial model was obtained by translat-
ing and rotating the protein and inhibitor coordinates taken from PDB
code 1okc to the position in space group C2221 [7]. The model was ﬁrst
optimized by alternative cycles of energy minimization, grouped B-fac-
tor reﬁnements using CNS [11] and manual corrections using O [12].
The electron density maps (2Fobs  Fcalc and Fobs  Fcalc) showed the
presence of three cardiolipins per AAC monomer. In order to reduce
possible overinterpretation of the densities due to limited resolution
and partial disorder of the lipids, cardiolipins were built independently
from two data sets (Table 1). The consistency of both models validates
the lipid positions. The complete model (protein, CATR and lipids)
was further reﬁned by simulated annealing at 5000 K on torsion anglesTable 1
Data collection and reﬁnement statistics
Data set Data set (1) Data set (2)
Space group C2221 C2221
Unit cell (A˚) 76.25; 110.75;
89.54
76.72; 110.06;
89.55
Resolution (A˚) 25–2.8 25–2.8
Rmerge (%)
a 10.8 (56.4)b 8.6 (32.9)b
Completeness (%) 99.9 (99.9)b 98.6 (100)b
ÆI/ræ 4.0 (1.1)b 5.3 (1.9)b
Reﬁnement statistics
Resolution (A˚) 25–2.8
Reﬂections working set (test set) 8976 (459)
Rcryst (Rfree) (%)
c 25.0 (28.1)
Number of non-hydrogen atoms 2515
aRmerge =
P
h
P
i|Ii(h)  ÆI(h)æ|/
P
h
P
iIi(h).
bNumbers in parentheses correspond to the highest resolution shell.
cRcryst =
P
h|Fobs(h)  Fcalc(h)|/
P
hFobs(h).followed by a grouped B-factor reﬁnement, to a ﬁnal Rcryst of 25.0%
and Rfree of 28.1% at 2.8 A˚ resolution. Reﬁnement statistics are given
in Table 1.3. Results
The ﬁnal model comprises residues 1–293 of the bovine
ADP/ATP carrier, one molecule of carboxyatractyloside and
three cardiolipins in the asymmetric unit. Residues 294–297
at the C-terminus are disordered and no electron density is vis-
ible. The N-terminus residues are present in the electron den-
sity although they exhibit high B-factors, denoting ﬂexibility.
All other residues as well as the inhibitor CATR are very sim-
ilar in position to model 1okc. Fig. 1 shows the overall fold of
AAC. The C2221 crystals contain three partially ordered cardi-
olipins located in the inner leaﬂet of the membrane. Only
atoms detected in the electron density maps are present in
the model. The phosphatidyl groups and the glycerol linker
of the cardiolipins are better localized than the extremities of
the four acyl chains (Fig. 4A). Additional phospholipids or
detergent molecules could not be built from the electron den-
sity. The three cardiolipins have similar locations to those ob-
served in P21212 crystals, and follow the pseudo threefold
symmetry of the protein. CDL800 is similar in position but dif-
fers in conformation. In this model the lipid sticks entirely on
the protein surface, whereas in the previous crystal form the li-
pid folds back on itself and only one half interacts directly with
the protein. CDL802 is only partially detected, but the visible
part is larger than in the previous crystal form. The most struc-
turally conserved lipid is CDL801, for which almost all the
molecule is present in the ﬁnal model. CDL801 also shows
the lowest B-factor among the three cardiolipins.Fig. 1. Ribbon diagram showing the overall fold of the ADP/ATP
carrier. The ribbon is colored from blue (N-terminus) to red (C-
terminus) and secondary structures are labeled. The protein is seen
from the side with respect to the membrane. Two out of the three
cardiolipins are shown with grey sticks surrounded by their van der
Waals surfaces, CATR is depicted in yellow. The subsequent ﬁgures
have the same color code and were drawn with the program PYMOL
(http://www.pymol.org).
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in Fig. 4B and C show how both phosphate groups of CDL801
interact with main chain nitrogens, the ﬁrst with I53 and I54
located at the N-ter of h1-2, the second with G272, A273,Fig. 2. Crystal packing in the centered crystal form. The crystal
packing along the b-axis highlights protein–protein interactions
occurring in the crystal. Monomers oriented in the same direction
are shown in blue (those viewed from the IMS) or red (those viewed
from the matrix). Interactions between neighboring carriers A and B or
C also involve cardiolipins, depicted in green. Positions of matrix small
helices are given for the central monomer, labeled A.
Fig. 3. Interactions between neighboring proteins: (A) proteins A and B; (B
(bottom).W274 and S275 located at the junction between loop M3
and H6. CDL800 exhibits similar interactions (L156, G157,
N158 located on h3-4 with one phosphate group, G72, L74
at the junction between M1 and H2 with the other). Aromatic
residues are also involved in protein–lipid interactions. W70,
Y173 and F270, residues that are related through the three tan-
demly repeated sequences, stack to acyl chains deriving from
one phosphate of CDL800, CDL802 and CDL801, respec-
tively. For example, interaction of CDL801 with F270 is
shown in Fig. 4C. In addition, the second branch of cardioli-
pins CDL801 and CDL802 interacts via a hydrogen bond
involving the indole nitrogen of W274 and W257, respectively.
The two crystal forms both grow as stacks of protein layers
in which transmembrane helices are oriented as if they were sit-
ting in a membrane. However, within one layer relative protein
orientations are very diﬀerent. The P21212 crystals from which
the structure to 2.2 A˚ resolution was solved [7] are built up by
monomers. Neighboring proteins related by crystallographic
symmetry are oriented in opposite direction (matrix side of
one molecule next to the intermembrane side of the other,
and vice versa), which was attributed to artefactual interac-
tions in the crystal packing since the carrier is asymmetrically
inserted in the mitochondrial membrane [13]. In contrast, the
C2221 crystal packing reveals neighboring carriers oriented
in the same direction as shown in Fig. 2. The carrier labeled
A has two neighboring molecules labeled B and C, which are
putative candidates for the second molecule of a dimer.
The interacting surface expends over 446 A˚2 between mono-
mers A and B and 76 A˚2 between monomers A and C. Exclud-
ing the lipids, the surfaces drop to 132 and 53 A˚2, respectively.
Indeed, interactions between A and C involve only protein–
protein interactions (Fig. 3B) between the N-terminus of one
molecule and the C-terminus of the other (K9A with I293B).
Proteins A and B interact both through direct protein–protein
contacts on the matrix side and in the intermembrane region
via the C2 loop and also through cardiolipins CDL801A and) proteins A and C, viewed from the side (top) and from the matrix
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(Fig. 3A). Direct protein–protein interactions are limited
mainly to a hydrogen bond between K267A and K51B on the
matrix, and to van der Waals interactions of M200A with
I210B, V211B and M214B. Lipid-mediated interactions are
more numerous. The glycerol linkage, the phosphates and part
of the acyl chains of CDL801 are within van der Waals dis-
tances of atoms belonging to the symmetry related lipid.4. Discussion
The oligomeric state of membrane proteins is more diﬃcult
to study than for soluble proteins and is often a matter of de-
bate. In several structures, oligomerization was described as
mediated by lipids [14–16]. Cardiolipins found to be located
at interfaces between monomers or subunits of complexes
(i.e., in cytochrome bc1, cytochrome c oxydase and formate
deshydrogenase N) seem to be especially important for associ-
ation of supermolecular complexes [17]. Intermolecular lipid-
mediated interactions between monomers can be stronger than
intramolecular interactions as demonstrated for bacteriorho-
dopsin by atomic force microscopy [18]. Interactions between
protein and lipids involve diﬀerent residues, hydrophobic resi-
dues in van der Waals contacts with acyl chains, aromatic res-
idues and more often tryptophans at the hydrophobic/
hydrophilic interface and polar or charged residues through
hydrogen bonds with lipid head groups. As a result, lipids
can be glued at protein surfaces through numerous weak inter-
actions. In addition, lipids probably contribute to the plasticity
of membrane complexes. Plasticity might be necessary for the
function, but also weakens the protein interactions during puri-
ﬁcation. On the other hand, concentrating proteins before and
during the crystallization in the presence of a large amount of
endogenous lipids, might favor natural protein–protein interac-
tions despite the presence of high detergent concentrations.
Examining the protein–protein contacts in various AAC
crystal forms might be of interest for understanding oligomer-
ization. The salt concentration in the buﬀer solution during the
last puriﬁcation step and during protein concentration is the
main diﬀerence leading to the two crystal forms. Primitive
crystals are obtained with a buﬀer containing 100 mM NaCl
while centered crystals appear in the presence of 0 or 5 mM
NaCl. In addition, going from 5 to 0 mM shrinks the centered
unit cell by almost 4 A˚ along the a-axis. The cell modiﬁcations
are eﬀective in the plane in which lateral protein–protein inter-
actions occur (Fig. 2). This suggests that modifying the NaCl
concentration during gel ﬁltration and most probably during
protein concentration modiﬁes protein–protein or protein–li-
pid–protein interactions. Low salt conditions could favor the
interactions leading to a prenucleation that would then guide
the crystallization. Even if the AAC dimers were disrupted
during the membrane extraction or the concentration of the
puriﬁed protein, they could be reconstituted in further pro-
cesses where protein–protein interactions are forced. Bacterio-
rhodopsin, a well characterized trimeric proton pump,
illustrates such a process as the protein after solubilization is
monomeric, while in the crystals, the trimers of the native
membrane are present indicating that crystallization favors
the native interactions [14]. Endogenous lipids that remain
bound to the protein during puriﬁcation are in this case cer-
tainly essential.Interactions between A and B are stronger than between A
and C. Although not very large, as compared to other protein
dimers, the interaction surface of A with B is signiﬁcantly lar-
ger than that of A with C. This surface mainly involves the
border of the transmembrane regions either in the matrix or
in the intermembrane space as shown in Fig. 3A. However,
the molecules interact more strongly on the matrix side where
two cardiolipins (CDL801A, associated with molecule A and
its symmetry related molecule CDL801B) strengthen the com-
plex by gluing the monomers together. The interactions of the
glycerol link and both phosphates of CDL801 with the protein,
mainly through hydrogen bonds, hold together the N-terminus
of helix h1-2 with the N-terminus of helix H6, thus contribut-
ing to the stabilization of the protein conformation (Fig. 4B).
Two other cardiolipins CDL800 and CDL802 have similar
interactions with h3-4/H2 and h5-6/H4, respectively. Fig. 4C
also highlights two hydrogen bonds between the Ne of K267
of one monomer and the symmetry related cardiolipin phos-
phate group PA1 and the carbonyl oxygen of K51. Therefore,
both through protein–lipid–protein or protein–protein interac-
tions the N-terminus of h1-2 is connected to the C-terminus of
h5-6 of the symmetry related carrier. These interactions are of
particular importance as the matrix loops including short heli-
ces are thought to be involved in conformational changes dur-
ing the transport mechanism [19]. Except for van der Waals
contacts along the two symmetry related lipids implicating acyl
chains, most of the interactions have a polar character, which
could account for a weakening of the whole complex (proteins
and lipids) in the presence of higher salt concentrations.
Although the resolution and the experimental conditions are
very diﬀerent (electron microscopy versus crystallography,
yeast protein instead of bovine protein), the protein–protein
interactions obtained in our three-dimensional crystal can be
compared to those deduced from two-dimensional crystals
[6]. Considering the diﬃculty in ﬁtting a molecular model in
a low resolution projection map, the dimer model proposed
from the electron microscopy [20], is consistent with the dimer
formed by molecules A and B with a slight rotation.
Covalent dimers of the yeast ADP/ATP carrier, where the C-
terminus of the ﬁrst monomer is fused to the N-terminus of the
second one, were found to be functional [21–23]. The transport
activity or inhibitor binding of chimeric proteins are similar to
the native ones. However, the segment bridging H6 from one
monomer to H1 from the other could, if unstructured, span
over more than 100 A˚, and is therefore consistent with both
A–B and A–C protein layouts.
Cross-link experiments targeting the cysteines of the three
short helices provide indirect structural information on the
dimer and conformational changes. The most favorable
cross-link occurs between C56 of two molecules but only in
the presence of BA. The cross-links were induced by cop-
per-o-phenanthroline [24] or using a 12 A˚ length linker [25].
The diﬀerences in accessibility and cross-link for C159 and
C256 as compared to C56, were interpreted as a ﬂuctuation
of the M1 loop (connecting H1 to H2 and including h1-2)
during the transport process that gives access to C56 in the
BA-induced conformation. Similar conclusions were drawn
from proteolysis experiments carried out on the beef carrier,
which demonstrated the conformation dependent unmasking
of the K42–Q43 bond in the presence of BA [13]. It has been
recently proposed from Cys-labeling experiments performed
on the yeast carrier in which individual H2 residues were mu-
Fig. 4. Close-up views of CDL801 and its interaction with proteins A
and B. (A) Electron density maps around CDL801, 2Fo  Fc and
Fo  Fc contoured at 1r and 3r, respectively, obtained before lipid
modeling, are shown in blue and red. (B) This panel highlights how the
cardiolipin clamps h1-2 and H6 together. Residues of monomer A
interacting with the phosphate groups of CDL801 are highlighted in
yellow. Monomer B is shown as transparent ribbon. (C) Interactions of
one phosphate group of CDL801B with h1-2 (implicating main chain
nitrogens) of molecule B and K267 side chain of molecule A are
shown. Lipids are depicted as ball-and-sticks in green, except phos-
phate groups in black. Dotted lines connect atoms within hydrogen-
bond distances. The panel also shows the interaction of F270A with
CDL801A acyl chains, and close contacts between cardiolipins chains.
The back line schematically marks the limit between the two
monomers.
H. Nury et al. / FEBS Letters 579 (2005) 6031–6036 6035tated into Cys and checked for accessibility, that H2 under-
goes a large twist during conformational changes [26]. Our
model shows that the Ca atoms of C56 from one monomerand C56 from the second monomer (C56A–C56B) are 28 A˚
apart and that the thiol groups are buried within the protein
in line with the labeling experiments that show that the pres-
ence of CATR does not allow the cross-link of none of the
cysteines. If, however, as proposed by Hashimoto et al.
[25], the M1 loop ﬂuctuates during the transport process
modifying helix h1-2, then C56 could become accessible and
it would be possible to cross-link C56A–C56B. Concomi-
tantly, helix H2 which is directly linked to h1-2 and which
is on the opposite face to dimerization could easily twist
without being constrained by extensive interactions.
Cardiolipins were shown to be tightly associated with
AAC with a stoichiometry of 3 per protein monomer [27].
However, their functional role is still a matter of debate. In-
deed, it was shown that cardiolipins are not essential for the
growth of yeast cells on fermentable and non-fermentable
carbon sources [28], but it was also shown that in the ab-
sence of cardiolipins AAC is defective since its activity is de-
creased to 20% of that of the wild type [29]. More
interestingly, it was shown that a yeast AAC mutant,
C73S (equivalent to C56 in the bovine AAC), reconstituted
in liposomes was inactive and that transport activity could
be at least partially recovered by adding cardiolipins to the
liposomes [30]. A local destabilization of h1-2 (induced by
the C73S mutation) close to the interface could aﬀect the
protein stability, destabilize the complex or hinder functional
conformational changes. If the M1 loop undergoes large
ﬂuctuations during the transport process [13,26], a mutation
could prevent a correct control of the movements and induce
irreversible structural modiﬁcations. Adding cardiolipins
could help in stabilizing the dimer and the structure by con-
trolling the conformational changes. This is in line with our
structural data showing that cardiolipins have a stabilizing
role. Because the interactions between two monomers are
also mediated by cardiolipins, we postulate that cardiolipins
could transmit conformational changes from one monomer
to the other and participate in triggering a concerted ADP/
ATP exchange.
In conclusion, in this new crystal form the interactions be-
tween two neighboring proteins in the crystal involving also
cardiolipin molecules (Fig. 3A), form a possible protein–pro-
tein interaction surface that is compatible with several experi-
mental observations published so far (electron microscopy,
accessibility and cross-link through Cys and yeast Cys mutant
reconstituted in liposomes with and without cardiolipins).
However, further experimental support, including structures
of other conformations adopted by the carrier during the
transport, is still necessary to ascertain the protein–protein
interaction and fully understand the transport mechanism
in vivo on a molecular basis.
Coordinates have been deposited in the Protein Data Bank
under accession code 2c3e.References
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